Patents by Inventor Seong Jun Yoon

Seong Jun Yoon has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10227570
    Abstract: The present invention relates to a Siphoviridae bacteriophage Lac-BRP-1 that is isolated from the nature and can kill Lactobacillus brevis cells specifically, which has a genome represented by the nucleotide sequence of SEQ. ID. NO: 1 (Accession NO: KCTC 12659BP), and a method for preventing and treating the contaminations of Lactobacillus brevis by using the composition comprising the bacteriophage as an active ingredient.
    Type: Grant
    Filed: January 5, 2016
    Date of Patent: March 12, 2019
    Assignee: INTRON BIOTECHNOLOGY, INC.
    Inventors: Seong Jun Yoon, Sang Hyeon Kang, Soo Youn Jun, Jee Soo Son, Hyoun Rok Paik, Byung Kuk Kim
  • Patent number: 10226060
    Abstract: The present invention relates to a Myoviridae bacteriophage Lac-GAP-1 that is isolated from the nature and can kill specifically Lactococcus garvieae cells, which has a genome represented by the nucleotide sequence of SEQ ID NO: 1 (Accession NO: KCTC 12686BP), and a method for preventing and treating the infections of Lactococcus garvieae using the composition comprising said bacteriophage as an active ingredient.
    Type: Grant
    Filed: January 5, 2016
    Date of Patent: March 12, 2019
    Assignee: INTRON BIOTECHNOLOGY, INC.
    Inventors: Seong Jun Yoon, Sang Hyeon Kang, Soo Youn Jun, An Sung Kwon, Soon Hye Hwang
  • Patent number: 10227571
    Abstract: The present invention relates to a Siphoviridae bacteriophage Lac-PLP-1 that is isolated from the nature and can kill Lactobacillus plantarum cells specifically, which has a genome represented by the nucleotide sequence of SEQ. ID. NO: 1 (Accession NO: KCTC 12665BP), and a method for preventing and treating the contaminations of Lactobacillus plantarum by using the composition comprising the bacteriophage as an active ingredient.
    Type: Grant
    Filed: January 5, 2016
    Date of Patent: March 12, 2019
    Assignee: INTRON BIOTECHNOLOGY, INC.
    Inventors: Seong Jun Yoon, Sang Hyeon Kang, Soo Youn Jun, Jee Soo Son, Hyoun Rok Paik, Hee Jeong Shin
  • Publication number: 20190000897
    Abstract: The present invention relates to a Podoviridae bacteriophage Vib-PAP-2 (Accession NO: KCTC 12910BP) that is isolated from the nature and can kill specifically Vibrio parahaemolyticus cells, which has a genome represented by the nucleotide sequence of SEQ. ID. NO: 1, and a method for preventing and treating the infections of Vibrio parahaemolyticus using the composition comprising said bacteriophage as an active ingredient.
    Type: Application
    Filed: November 10, 2016
    Publication date: January 3, 2019
    Inventors: Seong Jun Yoon, Soo Youn Jun, An Sung Kwon, Soon Hye Hwang, Sang Hyeon Kang
  • Publication number: 20180369300
    Abstract: The present invention relates to: Myoviridae bacteriophage Pas-MUP-1 (accession number KCTC 12706BP) which has the capability to specifically destroy Pasteurella multocida, is characterized by having a genome represented by SEQ ID NO: 1, and is isolated from nature; and a method for preventing and treating Pasteurella multocida infections, using a composition containing bacteriophage Pas-MUP-1 as an active ingredient.
    Type: Application
    Filed: November 10, 2016
    Publication date: December 27, 2018
    Inventors: Seong Jun Yoon, Soo Youn Jun, Hyoun Rok Paik, Jee Soo Son, Dong Min Kang, Sang Hyeon Kang
  • Publication number: 20180369299
    Abstract: The present invention relates to: Podoviridae bacteriophage Vib-PAP-1 (accession number KCTC 12817BP) which has the capability to specifically destroy Vibrio parahaemolyticus, is characterized by having a genome represented by SEQ ID NO: 1, and is isolated from nature; and a method for preventing and treating Vibrio parahaemolyticus infections, using a composition containing bacteriophage Vib-PAP-1 as an active ingredient.
    Type: Application
    Filed: November 10, 2016
    Publication date: December 27, 2018
    Inventors: Seong Jun Yoon, Soo Youn Jun, An Sung Kwon, Soon Hye Hwang, Sang Hyeon Kang
  • Patent number: 10156670
    Abstract: A polarizing film includes a high-temperature elongation film of a polyolefin and a dichroic dye, and the polyolefin has zero shear viscosity (?0) ranging from about 2600 Pa·s to about 17400 Pa·s at a temperature of about 210° C. (±3° C.).
    Type: Grant
    Filed: December 17, 2015
    Date of Patent: December 18, 2018
    Assignees: SAMSUNG ELECTRONICS CO., LTD., SAMSUNG SDI CO., LTD.
    Inventors: Feifei Fang, Beom Seok Kim, Seong-Jun Yoon, Dong Yun Lee, Boreum Jeong, Myung Sup Jung, Won Suk Chang
  • Publication number: 20180303885
    Abstract: The present invention relates to a Siphoviridae bacteriophage Str-INP-1 (Accession NO: KCTC 12687BP) that is isolated from the nature and can kill specifically Streptococcus iniae cells, which has a genome represented by the nucleotide sequence of SEQ. ID. NO: 1, and a method for preventing and treating the infections of Streptococcus iniae using the composition comprising said bacteriophage as an active ingredient.
    Type: Application
    Filed: September 30, 2016
    Publication date: October 25, 2018
    Inventors: Seong Jun Yoon, Soo Youn Jun, An Sung Kwon, Hyun Min Song, Sang Hyeon Kang
  • Publication number: 20180277362
    Abstract: Provided are a method of locally sealing only pores present in a surface part of a porous dielectric material by forming a polymer thin film through an initiated chemical vapor deposition (iCVD) method using an initiator, and a method of minimizing an increase in a dielectric constant induced therefrom.
    Type: Application
    Filed: March 16, 2018
    Publication date: September 27, 2018
    Inventors: Byung Jin Cho, Sung Gap Im, Seong Jun Yoon, Kwanyong Pak, Hyungsuk Alexander Yoon
  • Patent number: 10028984
    Abstract: The present invention relates to a Myoviridae bacteriophage Clo-PEP-1 that is isolated from the nature and can kill Clostridium perfringens cells specifically, which has the genome represented by nucleotide sequence of SEQ. ID. NO: 1 (Accession NO: KCTC 12664BP), and a method for preventing and treating the infections of Clostridium perfringens cells using the composition comprising said bacteriophage as an active ingredient.
    Type: Grant
    Filed: December 28, 2015
    Date of Patent: July 24, 2018
    Assignee: INTRON BIOTECHNOLOGY, INC.
    Inventors: Seong Jun Yoon, Sang Hyeon Kang, Soo Youn Jun, Jee Soo Son, Hyoun Rok Paik, Suk Hwang Park
  • Publication number: 20180119109
    Abstract: The present invention relates to a Siphoviridae bacteriophage Lac-PLP-1 that is isolated from the nature and can kill Lactobacillus plantarum cells specifically, which has a genome represented by the nucleotide sequence of SEQ. ID. NO: 1 (Accession NO: KCTC 12665BP), and a method for preventing and treating the contaminations of Lactobacillus plantarum by using the composition comprising the bacteriophage as an active ingredient.
    Type: Application
    Filed: January 5, 2016
    Publication date: May 3, 2018
    Inventors: Seong Jun Yoon, Sang Hyeon Kang, Soo Youn Jun, Jee Soo Son, Hyoun Rok Paik, Hee Jeong Shin
  • Publication number: 20180000125
    Abstract: The present invention relates to a Myoviridae bacteriophage Lac-GAP-1 that is isolated from the nature and can kill specifically Lactococcus garvieae cells, which has a genome represented by the nucleotide sequence of SEQ. ID. NO: 1 (Accession NO: KCTC 12686BP), and a method for preventing and treating the infections of Lactococcus garvieae using the composition comprising said bacteriophage as an active ingredient.
    Type: Application
    Filed: January 5, 2016
    Publication date: January 4, 2018
    Inventors: Seong Jun Yoon, Sang Hyeon Kang, Soo Youn Jun, An Sung Kwon, Soon Hye Hwang
  • Publication number: 20170369852
    Abstract: The present invention relates to a Siphoviridae bacteriophage Lac-BRP-1 that is isolated from the nature and can kill Lactobacillus brevis cells specifically, which has a genome represented by the nucleotide sequence of SEQ. ID. NO: 1 (Accession NO: KCTC 12659BP), and a method for preventing and treating the contaminations of Lactobacillus brevis by using the composition comprising the bacteriophage as an active ingredient.
    Type: Application
    Filed: January 5, 2016
    Publication date: December 28, 2017
    Inventors: Seong Jun Yoon, Sang Hyeon Kang, Soo Youn Jun, Jee Soo Son, Hyoun Rok Paik, Byung Kuk Kim
  • Publication number: 20170358488
    Abstract: Provided are methods of sealing open pores of a surface of a porous dielectric material using an initiated chemical vapor deposition (iCVD) process. In one example method of sealing open pores, since the polymer thin film having a significantly thin thickness may be formed by a solvent-free vapor deposition method without plasma treatment, it is possible to minimize deterioration of characteristics of the dielectric material vulnerable to plasma and a chemical solution.
    Type: Application
    Filed: August 25, 2016
    Publication date: December 14, 2017
    Inventors: Byung Jin Cho, Sung Gap Im, Seong Jun Yoon, Kwanyong Pak, Hyungsuk Alexander Yoon
  • Publication number: 20170348365
    Abstract: The present invention relates to a Myoviridae bacteriophage Esc-CHP-2 that is isolated from the nature and can kill specifically enteropathogenic E. coli strains, which has a genome represented by the nucleotide sequence of SEQ. ID. NO: 1 (Accession NO: KCTC 12661BP), and a method for preventing and treating the infections of enteropathogenic E. coli using the composition comprising said bacteriophage as an active ingredient.
    Type: Application
    Filed: December 28, 2015
    Publication date: December 7, 2017
    Inventors: Seong Jun Yoon, Sang Hyeon Kang, Soo Youn Jun, Hyoun Rok Paik, Jee Soo Son, Byung Kuk Kim, Hee Jeong Shin
  • Publication number: 20170340685
    Abstract: The present invention relates to a Myoviridae bacteriophage Clo-PEP-1 that is isolated from the nature and can kill Clostridium perfringens cells specifically, which has the genome represented by nucleotide sequence of SEQ. ID. NO: 1 (Accession NO: KCTC 12664BP), and a method for preventing and treating the infections of Clostridium perfringens cells using the composition comprising said bacteriophage as an active ingredient.
    Type: Application
    Filed: December 28, 2015
    Publication date: November 30, 2017
    Inventors: Seong Jun Yoon, Sang Hyeon Kang, Soo Youn Jun, Jee Soo Son, Hyoun Rok PAIK, Suk Hwang Park
  • Publication number: 20170340686
    Abstract: The present invention relates to a Myoviridae bacteriophage Esc-COP-1 that is isolated from the nature and can kill specifically Shigatoxin-producing type F18 E. coli strains, which has a genome represented by the nucleotide sequence of SEQ. ID. NO: 1 (Accession NO: KCTC 12662BP), and a method for preventing and treating the infections of Shigatoxin-producing type F18 E. coli using the composition comprising said bacteriophage as an active ingredient.
    Type: Application
    Filed: December 28, 2015
    Publication date: November 30, 2017
    Inventors: Seong Jun Yoon, Sang Hyeon Kang, Soo Youn Jun, Hyoun Rok Paik, Jee Soo Son, Suk Hwang Park, Byung Kuk Kim
  • Publication number: 20170333498
    Abstract: The present invention relates to a Myoviridae bacteriophage Esc-CHP-1 that is isolated from the nature and can kill specifically enterohemorrhagic E. coli strains, which has a genome represented by the nucleotide sequence of SEQ. ID. NO: 1 (Accession NO: KCTC 12660BP), and a method for preventing and treating the infections of enterohemorrhagic E. coli using the composition comprising said bacteriophage as an active ingredient.
    Type: Application
    Filed: December 28, 2015
    Publication date: November 23, 2017
    Inventors: Seong Jun Yoon, Sang Hyeon Kang, Soo Youn Jun, Hyoun Rok Paik, Jee Soo Son, Byung Kuk Kim, Hee Jeong Shin
  • Publication number: 20170333499
    Abstract: The present invention relates to a Myoviridae bacteriophage Esc-COP-4 that is isolated from the nature and can kill specifically enteroinvasive E. coli strains, which has a genome represented by the nucleotide sequence of SEQ. ID. NO: 1 (Accession NO: KCTC 12663BP), and a method for preventing and treating the infections of enteroinvasive E. coli using the composition comprising said bacteriophage as an active ingredient.
    Type: Application
    Filed: December 28, 2015
    Publication date: November 23, 2017
    Inventors: Seong Jun Yoon, Sang Hyeon Kang, Soo Youn Jun, Hyoun Rok Paik, Jee Soo Son, Byung Kuk Kim, Hee Jeong Shin, Dong Min Kang
  • Patent number: 9812670
    Abstract: A polarization film includes a polarization layer including a polymer and a dichroic dye having a maximum absorption wavelength (?max) at about 380 nm to about 780 nm, and a protective layer disposed on a surface of the polarization layer and having a cross-linking structure.
    Type: Grant
    Filed: June 26, 2015
    Date of Patent: November 7, 2017
    Assignee: SAMSUNG ELECTRONICS CO., LTD.
    Inventors: Hyun-Seok Choi, Sangah Gam, Seong-Jun Yoon